Each dose of Covishield and Covaxin likely to be capped at Rs 275 after getting regular market approval Read more
AstraZeneca Pharma India files writ petition in Delhi High Court against NPPA demand notice Read more
Govt in talks with manufacturers to ramp up availability of Amphotericin B to treat Mucormycosis Read more